- 专利标题： COMBINATION TREATMENT FOR SOLID TUMORS INCLUDING A STING AGONIST AND A CCR2 ANTAGONIST
-
申请号： US18624989申请日： 2024-04-02
-
公开(公告)号： US20240325565A1公开(公告)日： 2024-10-03
- 发明人: Song Li , Jingjing Sun
- 申请人： University of Pittsburgh - Of the Commonwealth System of Higher Education
- 申请人地址： US PA Pittsburgh
- 专利权人： University of Pittsburgh - Of the Commonwealth System of Higher Education
- 当前专利权人： University of Pittsburgh - Of the Commonwealth System of Higher Education
- 当前专利权人地址： US PA Pittsburgh
- 主分类号： A61K47/69
- IPC分类号： A61K47/69 ; A61K39/395 ; A61K47/58 ; A61K47/60
摘要：
A formulation including a nanostructure including an agent to activate a STING pathway in vivo and a C-C chemokine receptor type 2 (CCR2) antagonist.
信息查询
